ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 90 filers reported holding ALX ONCOLOGY HLDGS INC in Q4 2020. The put-call ratio across all filers is 0.71 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,423 | +21.2% | 215 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 215 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 215 | +60.4% | 0.00% | – |
| Q1 2022 | $2,000 | -93.3% | 134 | -66.5% | 0.00% | -100.0% |
| Q3 2021 | $30,000 | -54.5% | 400 | -66.7% | 0.01% | -46.7% |
| Q2 2021 | $66,000 | +10.0% | 1,200 | +71.4% | 0.02% | 0.0% |
| Q4 2020 | $60,000 | +900.0% | 700 | +366.7% | 0.02% | +650.0% |
| Q3 2020 | $6,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $715,272,000 | 67.97% |
| Logos Global Management LP | 3,156,981 | $232,796,000 | 22.72% |
| Vivo Capital, LLC | 4,220,048 | $311,186,000 | 10.94% |
| Foresite Capital Management IV, LLC | 785,945 | $57,956,000 | 6.94% |
| Foresite Capital Management V, LLC | 320,000 | $23,597,000 | 6.94% |
| Board of Trustees of The Leland Stanford Junior University | 518,822 | $38,258,000 | 3.38% |
| Cormorant Asset Management, LP | 881,770 | $65,022,000 | 1.45% |
| Redmile Group, LLC | 978,600 | $72,162,000 | 1.02% |
| SPHERA FUNDS MANAGEMENT LTD. | 130,351 | $9,612,000 | 0.74% |
| Artal Group S.A. | 525,000 | $38,714,000 | 0.68% |